CHRONIC ANTIBODY-MEDIATED TRANSPLANT REJECTION

Clinical trials for CHRONIC ANTIBODY-MEDIATED TRANSPLANT REJECTION explained in plain language.

Never miss a new study

Get alerted when new CHRONIC ANTIBODY-MEDIATED TRANSPLANT REJECTION trials appear

Sign up with your email to follow new studies for CHRONIC ANTIBODY-MEDIATED TRANSPLANT REJECTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

New hope for saving failing kidney transplants

Disease control Completed

This study tested whether adding the drug bortezomib to standard treatments could help control chronic rejection in kidney transplant patients. The trial involved 60 people whose bodies were attacking their transplanted kidneys with harmful antibodies. Researchers aimed to see if…

Matched conditions: CHRONIC ANTIBODY-MEDIATED TRANSPLANT REJECTION

Phase: PHASE2 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control

Last updated Apr 01, 2026 14:43 UTC

CHRONIC ANTIBODY-MEDIATED TRANSPLANT REJECTION

Get alerted when new CHRONIC ANTIBODY-MEDIATED TRANSPLANT REJECTION trials appear

New hope for saving failing kidney transplants